EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018

Zheng Yang, Daoqing Gong, Xinxiang He, Fei Huang, Yi Sun, Qinming Hu

Frontiers in Nutrition · 13.02.2023 · 10

DOI: 10.3389/fnut.2023.1113789 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Frontiers in Nutrition, online erschienen am 13.02.2023. Verfasst von Zheng Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic associated fatty liver disease (MAFLD) has become the most common liver disease globally, yet no new drugs have been approved for clinical treatment. Therefore, we investigated the relationship between dietary intake of soy-derived daidzein and MAFLD, to find potentially effective treatments.

Methods

We conducted a cross-sectional study using data from 1,476 participants in National Health and Nutrition Examination Survey (NHANES) from 2017 to 2018 and their associated daidzein intake from the flavonoid database in the USDA Food and Nutrient Database for Dietary Studies (FNDDS). We investigated the relationship between MAFLD status, controlled attenuation parameter (CAP), AST/Platelet Ratio Index (APRI), Fibrosis-4 Index (FIB-4), liver stiffness measurement (LSM), nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS), hepatic steatosis index (HSI), fatty liver index (FLI), and daidzein intake by adjusting for confounding variables using binary logistic regression models and linear regression models.

Results

In the multivariable-adjusted model II, there was a negative association between daidzein intake and the incidence of MAFLD (OR for Q4 versus Q1 was 0.65, 95% confidence interval [CI] = 0.46–0.91, p = 0.0114, p for trend was 0.0190). CAP was also negatively associated with daidzein intake, β = −0.37, 95% CI: −0.63 to −0.12, p = 0.0046 in model II after adjusting for age, sex, race, marital status, education level, family income-to-poverty ratio (PIR), smoking, and alcohol consumption. Stratified by quartiles of daidzein intake, trend analysis of the relationship between daidzein intake and CAP remained significant ( p for trend = 0.0054). In addition, we also found that HSI, FLI, and NFS were negatively correlated with daidzein intake. LSM was negatively related to daidzein intake but had no statistical significance. The correlation between APRI, FIB-4, and daidzein intake was not strong (although p < 0.05, β values were all 0).

Conclusion

We found that MAFLD prevalence, CAP, HSI, and FLI, all decreased with increased daidzein intake, suggesting that daidzein intake may improve hepatic steatosis. Therefore, dietary patterns of soy food or supplement consumption may be a valuable strategy to reduce the disease burden and the prevalence of MAFLD.

Schlagwörter

Stichwörter der Autor:innen

MAFLDNHANESdaidzeinhepatic fibrosishepatic steatosis

Autor:innen und Institutionen

  • Department of Infectious Disease, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.
  • Teaching Office, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.
  • Department of Dermatology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, China.

Förderung

  • Natural Science Foundation of Hubei Province

Zitieren

APA

Yang, Z., Gong, D., He, X., Huang, F., Sun, Y., & Hu, Q. (2023). Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018. Frontiers in Nutrition, 10. https://doi.org/10.3389/fnut.2023.1113789

Vancouver

Yang Z, Gong D, He X, Huang F, Sun Y, Hu Q. Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018. Frontiers in Nutrition. 2023;10. doi:10.3389/fnut.2023.1113789

BibTeX
@article{Yang2023,
  author = {Yang, Zheng and Gong, Daoqing and He, Xinxiang and Huang, Fei and Sun, Yi and Hu, Qinming},
  title = {Association between daidzein intake and metabolic associated fatty liver disease: A cross-sectional study from NHANES 2017–2018},
  journal = {Frontiers in Nutrition},
  year = {2023},
  volume = {10},
  doi = {10.3389/fnut.2023.1113789}
}
Kostenlos starten →